| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH |
From the Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden; and the Department of Cell Biology, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford, New Jersey.
Address reprint requests to: K. Gemzell Danielsson, MD, PhD Department of Woman and Child Health Division for Obstetrics & Gynecology Karolinska Hospital S-171 76, Stockholm Sweden
Objective: To compare the degree of absorption and the effect on uterine contractility of the prostaglandin E1 analogue misoprostol after vaginal and oral administration.
Methods: Thirty women with a normal intrauterine pregnancy between 8 and 11 weeks’ gestation who requested termination of pregnancy were given either 0.2 mg (orally n = 5; vaginally n = 6) or 0.4 mg (orally n = 10; vaginally n = 9) of misoprostol. Intrauterine pressure was recorded using a Grass polygraph connected to a pressure transducer 30 minutes before misoprostol was given and for 4 hours thereafter. At the end of the recording, suction curettage was performed. Blood samples were obtained at 0, 0.5, 1, 2, 4, and 6 hours for measurement of misoprostol, which was assayed by high-pressure liquid chromatography–mass spectrometry.
Results: In all patients, the first effect was an increase in uterine tonus. After 0.4 mg of misoprostol administered orally, uterine tonus started to increase after a mean (± standard deviation) time of 7.8 ± 3.0 minutes and reached its maximum after 25.5 ± 5.0 minutes. The corresponding times after vaginal administration were 20.9 ± 5.3 minutes and 46.3 ± 20.7 minutes, respectively. The initial increase in tonus was also more pronounced after oral than after vaginal administration. After vaginal administration, all patients developed uterine contractions; the activity, measured in Montevideo units, increased continuously during the observation period. This was not the case after oral administration. Plasma levels of misoprostol were measured in 18 patients. The highest levels were found 30 minutes after oral treatment and 1–2 hours after vaginal administration.
Conclusion: The long-lasting and continuously increasing uterine contractility after vaginal administration can be explained only in part by a direct effect of misoprostol. The longer period of elevated plasma levels of misoprostol may also have initiated the prolonged events leading to increased uterine contractility.
This article has been cited by other articles:
|
|
 |
|
  S.-Y. Cheng, H. Ming, and J.-C. Lee Titrated Oral Compared With Vaginal Misoprostol for Labor Induction: A Randomized Controlled Trial Obstet. Gynecol., January 1, 2008; 111(1): 119 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Saav, A. Aronsson, L. Marions, O. Stephansson, and K. Gemzell-Danielsson Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial Hum. Reprod., October 1, 2007; 22(10): 2647 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aronsson, C. Fiala, O. Stephansson, F. Granath, B. Watzer, H. Schweer, and K. Gemzell-Danielsson Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol Hum. Reprod., July 1, 2007; 22(7): 1912 - 1918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lalitkumar, M. Bygdeman, and K. Gemzell-Danielsson Mid-trimester induced abortion: a review Hum. Reprod. Update, January 1, 2007; 13(1): 37 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Meckstroth, A. K. Whitaker, S. Bertisch, A. B. Goldberg, and P. D. Darney Misoprostol Administered by Epithelial Routes: Drug Absorption and Uterine Response. Obstet. Gynecol., September 1, 2006; 108(3): 582 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fiala, A. Aronsson, F. Granath, O. Stephansson, H.W. Seyberth, B. Watzer, and K. Gemzell-Danielsson Pharmacokinetics of a novel oral slow-release form of misoprostol Hum. Reprod., December 1, 2005; 20(12): 3414 - 3418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fiala, M.L. Swahn, O. Stephansson, and K. Gemzell-Danielsson The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation Hum. Reprod., November 1, 2005; 20(11): 3072 - 3077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Lin, F. S. Nuthalapaty, A. R. Carver, A. S. Case, and P. S. Ramsey Misoprostol for Labor Induction in Women With Term Premature Rupture of Membranes: A Meta-Analysis Obstet. Gynecol., September 1, 2005; 106(3): 593 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fiala, A. Aronsson, O. Stephansson, and K. Gemzell-Danielsson Effects of slow release misoprostol on uterine contractility in early pregnancy Hum. Reprod., September 1, 2005; 20(9): 2648 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Wolf, L. Sanchez-Ramos, and A. M. Kaunitz Sublingual Misoprostol for Labor Induction: A Randomized Clinical Trial Obstet. Gynecol., February 1, 2005; 105(2): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Saxena, S. Salhan, and N. Sarda Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in first trimester abortions Hum. Reprod., January 1, 2004; 19(1): 77 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aronsson, M. Bygdeman, and K. Gemzell-Danielsson Effects of misoprostol on uterine contractility following different routes of administration Hum. Reprod., January 1, 2004; 19(1): 81 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Dickinson and S. F. Evans A Comparison of Oral Misoprostol With Vaginal Misoprostol Administration in Second-Trimester Pregnancy Termination for Fetal Abnormality Obstet. Gynecol., June 1, 2003; 101(6): 1294 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kleinhaus, S. Teal, A. Chittacharoen, Y. Herabutya, and P. Punyavachira A Randomized Trial of Oral and Vaginal Misoprostol to Manage Delivery in Cases of Fetal Death Obstet. Gynecol., June 1, 2003; 101(6): 1353 - 1354. [Full Text] [PDF]
|
|
|
|
|
|
Y.-S. Chong, S. Chua, and S. Arulkumaran Sublingual misoprostol for first trimester termination of pregnancy: safety concerns Hum. Reprod., October 1, 2002; 17(10): 2777 - 2777. [Full Text] [PDF]
|
|
|
|
|
|
H. Honkanen, S. Ranta, O. Ylikorkala, and O. Heikinheimo The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy Hum. Reprod., September 1, 2002; 17(9): 2315 - 2319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. S. Tang, H. Schweer, H.W. Seyberth, S. W.H. Lee, and P. C. Ho Pharmacokinetics of different routes of administration of misoprostol Hum. Reprod., February 1, 2002; 17(2): 332 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.W. Pang, T.S. Lee, and T.K.H. Chung Incomplete miscarriage: a randomized controlled trial comparing oral with vaginal misoprostol for medical evacuation Hum. Reprod., November 1, 2001; 16(11): 2283 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bartley, A. Brown, R. Elton, and D. T. Baird Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation Hum. Reprod., October 1, 2001; 16(10): 2098 - 2102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Carlan, S. Bouldin, D. Blust, and W. F. O'Brien Safety and Efficacy of Misoprostol Orally and Vaginally: A Randomized Trial Obstet. Gynecol., July 1, 2001; 98(1): 107 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. G. CRANE, D. C. YOUNG, K. D. BUTT, K. A. BENNETT, and D. HUTCHENS Excessive Uterine Activity Accompanying Induced Labor Obstet. Gynecol., June 1, 2001; 97(6): 926 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sanchez-Ramos, A. M. Kaunitz, M. L. Stitely, J. Browning, and R. B. Gherman OUTPATIENT CERVICAL RIPENING WITH INTRAVAGINAL MISOPROSTOL Obstet. Gynecol., February 1, 2001; 97(2): 325 - 326. [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Goldberg, M. B. Greenberg, and P. D. Darney Misoprostol and Pregnancy N. Engl. J. Med., January 4, 2001; 344(1): 38 - 47. [Full Text] [PDF]
|
|
|
|
|
|
P.S. Ng, A.S.M. Chan, W.K. Sin, L.C.H. Tang, K.B. Cheung, and P.M. Yuen A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour Hum. Reprod., January 1, 2001; 16(1): 31 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Christin-Maitre, P. Bouchard, and I. M. Spitz Medical Termination of Pregnancy N. Engl. J. Med., March 30, 2000; 342(13): 946 - 956. [Full Text] [PDF]
|
|
|
|
|
|
S.-K. YIP, A. O.-K. TSE, C. J. HAINES, and T. K.-H. CHUNG Misoprostol's Effect on Uterine Arterial Blood Flow and Fetal Heart Rate in Early Pregnancy Obstet. Gynecol., February 1, 2000; 95(2): 232 - 235. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
